ZJ2-11848-45650
3 vaccinations
2 coded responses
8 check-ins
2 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 116 / NY
- Registered
- 2021-01-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-12
Dose 1 — Moderna
-
2021-01-17
Registered in v-safe
-
2021-01-17
Survey response — days 1–6 daily, dose 1MedDRA: Headache, Loss of personal independence in daily activities, Myalgia, Nausea — Feeling: Good · Site: Pain · Muscle or body achesFree text: On January 13 I had headache, nausea, muscle aches that prevented me from functioning normally. They improved on the 14th and resolved on the 15th.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-18
- 2021-01-21
- 2021-01-26
- 2021-02-02
-
2021-02-09
Dose 2 — Moderna
- 2021-02-16
- 2021-03-03
-
2022-01-06
Dose 3 — Pfizer-BioNTech
-
2022-02-11
Survey response — day 35, dose 3MedDRA: Atrioventricular block, Atrioventricular block second degree, Cardiac pacemaker insertion, Emergency care, Fatigue, Hepatic enzyme increased, Hospitalisation, Office visit, Pain, Red blood cell sedimentation rate increased — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationFree text: Symptoms: Vaccine on January 6 followed in 24 hours fatigue aches continued. Diagnosed second degree heart 1/15. Complete heart block 1/18 urgent pacemaker placed, hospitalized. ?Related to vaccine. Sed rate 35. Treponin negative. Elevated liver enzyme call me · Healthcare visit (other): Cardiology twiceMedDRA releases: 2024-11 · check-in free text available
-
2022-02-11
Report sent to call center — day 35, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
-
2022-02-15
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Moderna | |
| 2 | 2021-02-09 | Moderna | |
| 3 | 2022-01-06 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-11 | Successful 2022-02-15 |
Participant prefers to complete VAERS report online |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): On January 13 I had headache, nausea, muscle aches that prevented me from functioning normally. They improved on the 14th and resolved on the 15th.
Release 11 — day 35, dose 3
Symptoms: Vaccine on January 6 followed in 24 hours fatigue aches continued. Diagnosed second degree heart 1/15. Complete heart block 1/18 urgent pacemaker placed, hospitalized. ?Related to vaccine. Sed rate 35. Treponin negative. Elevated liver enzyme call me cut off by CDC
Healthcare visit (other): Cardiology twice
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Atrioventricular block | · | · | ✓ |
| SD | Atrioventricular block second degree | · | · | ✓ |
| SD | Cardiac pacemaker insertion | · | · | ✓ |
| SD | Emergency care | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hepatic enzyme increased | · | · | ✓ |
| SD | Hospitalisation | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Red blood cell sedimentation rate increased | · | · | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Loss of personal independence in daily activities | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
| SRO | Nausea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release